10 Losing Stocks in an Otherwise Optimistic Market
Ten stocks ended on a lackluster performance on Wednesday, defying an overall market optimism, as investors took path from a series of corporate news, alongside the lack of positive...
Insider Monkey Blog
Evercore Notes AbbVie Inc.’s (ABBV) Tremfya Gains Market Share, But Future Earnings Growth May Be Limited
TheFly reported on February 4 that Evercore ISI lowered its price target on ABBV to $228 from $232 and maintained an Outperform rating.
Needham Bullish on Neurocrine Biosciences, Inc. (NBIX) Pipeline Amid 2026 Growth Expectations for Crenessity and Ingrezza
TheFly reported on February 12 that Needham lowered its price target on NBIX to $185 from $187 and maintained a Buy rating. The company is still hopeful about Crenessity...
Jefferies Assigns 65–75% Probability of Best-in-Class Efficacy for Definium Therapeutics, Inc.’s (DFTX) DT120 in Phase III
TheFly reported on January 30 that Jefferies initiated coverage of DFTX with a Buy rating and a $30 price target.
Analysts Bullish on COMPASS Pathways plc (CMPS) Following Psychedelics Symposium and Model Updates
TheFly reported on February 14 that LifeSci Capital was bullish on CMPS, as the firm initiated coverage on the stock with a Buy rating and a $15 price target.
Baird Lowers Bright Minds Biosciences Inc. (DRUG) Price Target to $126, Maintains Outperform Rating Ahead of Upcoming Trials
TheFly reported on February 13 that Baird lowered its price target for DRUG to $126 from $142 and maintained an Outperform rating on the shares.
RBC Capital Cite GH Research PLC’s (GHRS) Long-Term Sales Potential Following Psychedelics Symposium
TheFly reported that on January 23, RBC Capital raised its price target on GHRS to $40 from $33 and maintained an Outperform rating.
Jeffries Highlight Cybin D/B/A Helus Pharma (HELP)’s Science-Driven Psilocybin Therapies as Key Growth Drivers
TheFly reported on February 2 that Jefferies initiated coverage of HELP with a Buy rating and a $22 price target and also highlighted significant upside potential.
Goldman Sachs See Teva Pharmaceutical Industries Limited (TEVA) Driving Double-Digit Earnings Growth Through 2026
TheFly reported on February 9 that Goldman Sachs raised its price target on TEVA to $45 from $36, and gave it a Buy rating.
10 Best Growth Stocks to Buy for the Next 20 Years
On February 13, Chief Market Strategist at Carson Group Ryan Detrick and CEO of MCC Global Enterprises Michelle Caruso-Cabrera joined CNBC to discuss rising geopolitical tensions...
12 Best Affordable Stocks Under $40 to Buy
On February 17, Jeremy Siegel, professor emeritus of finance at the University of Pennsylvania’s Wharton School of Business, appeared on a CNBC television interview to talk...
TD Cowen Lowers Aurora Innovation (AUR) PT, Cites Soft 2026 Guidance Despite Growth Inflection Outlook
Aurora Innovation Inc. (NASDAQ:AUR) is one of the best single digit stocks to buy according to analysts.
Morgan Stanley Names Rocket Pharmaceuticals (RCKT) as Key Beneficiary of 2026 Biotech Sector Recovery
Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) is one of the best single digit stocks to buy according to analysts.
Wells Fargo Cites Legend Acquisition Uncertainty as Potential Headwind for Genius Sports (GENI) Valuation
Genius Sports Limited (NYSE:GENI) is one of the best single digit stocks to buy according to analysts.
CleanSpark (CLSK): Keefe Bruyette Maintains Positive Outlook on Sealy Project Despite ERCOT Batch Study Uncertainty
CleanSpark Inc. (NASDAQ:CLSK) is one of the best single digit stocks to buy according to analysts.
PagerDuty (PD): Truist Cites AI Narratives, Terminal Value Concerns as Key Drivers for Infrastructure Software
PagerDuty Inc. (NYSE:PD) is one of the best single digit stocks to buy according to analysts.
BofA Lowers Teladoc (TDOC) PT on Peer Multiple Compression, Soft Sensor Tower Trends
Teladoc Health Inc. (NYSE:TDOC) is one of the best single digit stocks to buy according to analysts.
Needham Initiates Amprius Technologies (AMPX) as Key Pure-Play Unmanned Aerial Systems Supplier
Amprius Technologies Inc. (NYSE:AMPX) is one of the best single digit stocks to buy according to analysts.
Is Freshworks (FRSH) One of the Best Single Digit Stocks to Buy According to Analysts?
Freshworks Inc. (NASDAQ:FRSH) is one of the best single digit stocks to buy according to analysts.
Citi Lowers Snap (SNAP) PT to $6, Cites Persistent Brand Advertising Headwinds
Snap Inc. (NYSE:SNAP) is one of the best single digit stocks to buy according to analysts.
JPMorgan Initiates TIC Solutions (TIC) Highlighting NV5 Integration and Cross-Selling Synergies
TIC Solutions Inc. (NYSE:TIC) is one of the best single digit stocks to buy according to analysts.
Mahindra Selects Mobileye’s (MBLY) EyeQ6 ADAS for Future Vehicle Lineup
Mobileye Global Inc. (NASDAQ:MBLY) is one of the best single digit stocks to buy according to analysts.
Barclays Adjusts ACV Auctions (ACV) Target Amid Momentum in Used Vehicle Market
ACV Auctions Inc. (NYSE:ACVA) is one of the best single digit stocks to buy according to analysts.
Wells Fargo Cautious on Praxis Precision (PRAX) After Recent Revenue Estimates
Praxis Precision Medicines Inc. (NASDAQ:PRAX) is one of the 13 hot stocks to buy with the highest upside potential.
End of Apogee (APGE) Drug Collaboration Leads to Revised Analyst Expectations
Apogee Therapeutics Inc. (NASDAQ:APGE) is one of the 13 hot stocks to buy with the highest upside potential.
Morgan Stanley Positive on Cipher Mining (CIFR) Data Center Potential
Cipher Mining Inc. (NASDAQ:CIFR) is one of the 13 hot stocks to buy with the highest upside potential. On February 9, Morgan Stanley started covering Cipher Mining Inc.
Analyst Bullish on Beam Therapeutics (BEAM) Over Drug Program Trajectory
Beam Therapeutics Inc. (NASDAQ:BEAM) is one of the 13 hot stocks to buy with the highest upside potential.
Vaxcyte (PCVX) $632.5M Stock Offering Follows Bullish Cantor Fitzgerald Rating
Vaxcyte Inc. (NASDAQ:PCVX) is one of the 13 hot stocks to buy with the highest upside potential. On February 2, Vaxcyte Inc.
Analysts Bullish on Vera Therapeutics (VERA) Amid New Commercial Chief Appointment
Vera Therapeutics Inc. (NASDAQ:VERA) is one of the 13 hot stocks to buy with the highest upside potential.
Morgan Stanley Cautious on Nebius (NBIS) Following NVIDIA Platform Deployment
Nebius Group NV (NASDAQ:NBIS) is one of the 13 hot stocks to buy with the highest upside potential.
TD Cowen Cautious on Amicus Therapeutics (FOLD) Despite Positive 2025 Revenue Projections
Amicus Therapeutics Inc. (NASDAQ:FOLD) is one of the 13 hot stocks to buy with the highest upside potential.
ImmunityBio (IBRX) Clinical Trial for Lymphona Drug Follows $505M Convertible Note Change
ImmunityBio Inc. (NASDAQ:IBRX) is one of the 13 hot stocks to buy with the highest upside potential. On February 2, ImmunityBio Inc.
Critical Report on Ondas (ONDS) Precedes Defense Unit’s $30M Contract in Israel
Ondas Inc. (NASDAQ:ONDS) is one of the 13 hot stocks to buy with the highest upside potential. On February 9, Ondas Inc.
Analysts Confirm Bullish Outlook on Wave Life (WVE) Over Obesity Treatment
Wave Life Sciences Ltd. (NASDAQ:WVE) is one of the 13 hot stocks to buy with the highest upside potential. On February 5, BofA initiated coverage of Wave Life Sciences Ltd.
Bullish Analyst Opinion on Dyne (DYNE) Follows Rare Disease Drug Progress in Japan
Dyne Therapeutics Inc. (NASDAQ:DYN) is one of the 13 hot stocks to buy with the highest upside potential.
Analysts Bullish on Crinetics (CRNX) Amid Positive Clinical Trial for New Drug
Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) is one of the 13 hot stocks to buy with the highest upside potential.
Novig Raises $75M Series B to Build a Trader-First Sports Prediction Market
Novig, the fastest growing sports trading platform in America, today announced the close of a $75 million Series B round led by Pantera Capital, with participation from Multicoin...
10 Market Winners With Stunning Gains
Ten stocks clocked strong gains on Wednesday as investor appetite was boosted by a flurry of corporate earnings and acquisition initiatives.
11 Best Natural and Organic Food Stocks to Buy Now
On February 17, Mohamed El-Erian, chief economic advisor at Allianz, appeared on CNBC’s ‘Squawk on the Street’ to talk about the market’s economic themes and the state...
Goldman Sachs EV and Battery Stocks: Top 10 Stock Picks
On February 13, 2026, Reuters cited Benchmark Mineral Intelligence and reported that global EV registrations dropped 3% year over year to around 1.2 million units in January. ...
Lime Co-Founder Brad Bao Named in $100 Million Federal RICO Lawsuit Alleging Massive Crypto Token Fraud
Brad Bao is best known for building Lime into one of the world’s largest electric scooter companies—a venture that reached a $2.4 billion valuation and put shared micro-mobility...
12 Best Immunotherapy Stocks to Buy According to Hedge Funds
On February 13, Matt Orton, Raymond James Investment Management's chief market strategist, appeared on CNBC’s ‘The Exchange’ to talk about the recent trends in equity markets...
Hedge Fund and Insider Trading News: Bill Ackman, Ray Dalio, David Einhorn, Appaloosa Management, Brevan Howard Asset Management, Maverick Capital, Viking Global, DraftKings Inc (DKNG), Avantor Inc (AVTR), and More
You may be concerned about the recent declines in AI stocks such as NVDA.
12 Best Luxury Stocks to Buy Now
On February 13, Mark Zandi, Moody’s Analytics chief economist, and Jim Paulsen, former chief investment strategist at The Leuthold Group and author of Paulsen Perspectives, ...
13 Best Infrastructure Stocks to Buy Right Now
Infrastructure companies are the backbone of industrial economies. These organizations build, own, or operate the long-life assets that economic activity depends on.
Jim Cramer Believes Crowdstrike (CRWD) Shouldn’t Be Afraid of Anthropic
CrowdStrike Holdings, Inc. (NASDAQ:CRWD) is a cybersecurity software services provider. The shares are down by 5.7% over the past year and by 5.3% year-to-date.
Jim Cramer Discusses Thomson Reuters (TRI) Stock
Thomson Reuters Corporation (NASDAQ:TRI) is a legal, professional services, and news media company. The shares are down by 49% over the past year and by 31% year-to-date.
Jim Cramer Discusses Gartner (IT) Stock
Gartner, Inc. (NYSE:IT) is one of the largest information technology services firms in the world.
Jim Cramer Believes Adobe’s (ADBE) In Trouble
Adobe Inc (NASDAQ:ADBE) is one of the largest productivity software providers in the world. Its shares are down by 43% over the past year and by 20% year-to-date.
Jim Cramer Discusses Salesforce (CRM) Stock
Salesforce Inc (NYSE:CRM) is a customer relationship management software provider. The shares are down by 42% over the past year and by 25% year-to-date.
Hedge Fund Resource Center
